Johnson & Johnson
JNJ
$224.26
$2.831.28%
NYSE
| 03/29/2026 | 12/28/2025 | 09/28/2025 | 06/29/2025 | 03/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 24.06B | 24.56B | 23.99B | 23.74B | 21.89B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.06B | 24.56B | 23.99B | 23.74B | 21.89B |
| Cost of Revenue | 8.09B | 7.81B | 7.29B | 7.61B | 7.35B |
| Gross Profit | 15.98B | 16.75B | 16.70B | 16.13B | 14.54B |
| SG&A Expenses | 5.85B | 6.61B | 5.78B | 5.75B | 4.98B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.47B | 18.68B | 16.75B | 16.88B | 15.56B |
| Operating Income | 6.60B | 5.89B | 7.25B | 6.86B | 6.34B |
| Income Before Tax | 5.99B | 4.97B | 7.49B | 6.49B | 13.63B |
| Income Tax Expenses | 755.00M | -150.00M | 2.34B | 954.00M | 2.63B |
| Earnings from Continuing Operations | 5.24B | 5.12B | 5.15B | 5.54B | 11.00B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.24B | 5.12B | 5.15B | 5.54B | 11.00B |
| EBIT | 6.60B | 5.89B | 7.25B | 6.86B | 6.34B |
| EBITDA | 8.60B | 7.90B | 9.02B | 8.81B | 8.11B |
| EPS Basic | 2.17 | 2.10 | 2.14 | 2.30 | 4.57 |
| Normalized Basic EPS | 1.66 | 1.54 | 1.89 | 1.81 | 1.74 |
| EPS Diluted | 2.14 | 2.10 | 2.12 | 2.29 | 4.54 |
| Normalized Diluted EPS | 1.64 | 1.54 | 1.87 | 1.80 | 1.73 |
| Average Basic Shares Outstanding | 2.41B | 2.44B | 2.41B | 2.41B | 2.41B |
| Average Diluted Shares Outstanding | 2.45B | 2.44B | 2.43B | 2.42B | 2.42B |
| Dividend Per Share | 1.30 | 1.30 | 1.30 | 1.30 | 1.24 |
| Payout Ratio | 59.81% | 61.20% | 60.79% | 56.51% | 27.18% |